CAE Healthcare acquires Blue Phantom to expand ultrasound imaging simulation business
CAE Healthcare and Blue Phantom™ today announced that CAE has acquired Blue Phantom, a world leader in the ultrasound medical imaging simulation business. The addition of Blue Phantom will advance CAE’s healthcare simulation vision and help customers worldwide in their pursuit to improve clinical training and delivery of patient care.
The Blue Phantom acquisition enables CAE to expand its healthcare simulation business by integrating tissue-based simulation into its product offerings as well as enhancing its world-class human patient simulators, including its VIMEDIX™ line of computer based ultrasound simulators.
"We are excited to have Blue Phantom become part of CAE Healthcare. We have identified the booming market for handheld ultrasound devices as one of the most promising for simulation-based training. CAE Healthcare already established its leadership in this field with our VIMEDIX family of simulators and we are now adding the finest manufacturer of ultrasound task trainers to our portfolio. Blue Phantom's technology will become a cornerstone of future development for CAE Healthcare, as well," said Michael Bernstein, President of CAE Healthcare.
Guided ultrasound has become a standard of care for a number of procedures and over the coming years, practicing physicians and other healthcare professionals around the world will need the hands-on training in ultrasound that only simulation can provide.
CAE Healthcare will now offer a comprehensive product line for both ultrasound imaging diagnostics in virtual reality and ultrasound-guided interventions with phantoms training for anesthesiology, cardiology, critical care, emergency medicine, endocrinology, infusion nursing, nephrology, obstetrics and gynecology, pediatrics, pulmonology, radiology and surgery.
Learn more about Blue Phantom at www.bluephantom.com